Methacholine

DRUG7 trials

Sponsors

University of Florida, Syntara, Guangzhou Institute of Respiratory Disease, Zhujiang Hospital, University of Alberta

Conditions

AsthmaMild Asthma

Phase 3

Ability of Aridol to Detect Bronchial Hyperresponsiveness in Suspected Asthmatics

CompletedNCT00252291

Start: 2005-11-30End: 2006-09-30Target: 240Updated: 2009-12-01

The Effect of Deep Inhalation on Mannitol Responsiveness

CompletedNCT03505489

University of SaskatchewanAsthma

Start: 2018-06-01End: 2019-04-30Updated: 2019-05-15

Phase 4

Assessment of Airway Responsiveness and Treatment Efficacy in Asthmatics

Zhujiang HospitalAsthma

Start: 2015-04-30End: 2016-05-31Target: 80Updated: 2015-10-16

Unknown Phase

The Impact of Dosimeter on Measurement of Airway Responsiveness to Methacholine

CompletedNCT00145990

University of FloridaAsthma

Start: 2005-09-30End: 2005-12-31Target: 12Updated: 2012-03-05

Comparison of Methacholine Bronchial Provocation With Wright and Devilbiss646 Nebulizers

CompletedNCT02502825

Guangzhou Institute of Respiratory DiseaseAsthma

Start: 2015-07-31End: 2016-12-31Updated: 2018-02-19

Asthma Exacerbations and Vascular Function

CompletedNCT02630511

University of AlbertaAsthma

Start: 2015-12-31End: 2020-12-31Updated: 2021-07-01

Pharmacodynamic Equivalence of the Test and Reference Metered Dose Inhalers (MDIs) Containing Albuterol Sulfate in Adult Patients With Stable Mild Asthma

RecruitingNCT04912596

Intech Biopharm Ltd.Mild Asthma

Start: 2022-08-15End: 2025-06-30Target: 148Updated: 2025-02-17

Related Papers

Impact of airway challenges on cardiovascular risk in asthma – a randomized controlled trial

PLoS ONE2023-07-173 citations

The effect of deep inhalation on mannitol responsiveness.

2019-12-142 citations

Respiratory Duty Cycles in Individuals With and Without Airway Hyperresponsiveness.

2019-09-196 citations